Noriaki Manabe Selected Research

Gastrointestinal Hemorrhage (Hematochezia)

1/2024	A novel prediction tool for mortality in patients with acute lower gastrointestinal bleeding requiring emergency hospitalization: a large multicenter study.
11/2023	Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases.
7/2023	Multicenter propensity score-matched analysis comparing short versus long cap-assisted colonoscopy for acute hematochezia.
1/2023	Timing of colonoscopy in acute lower GI bleeding: a multicenter retrospective cohort study.
1/2023	Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia.
11/2021	Identifying Bleeding Etiologies by Endoscopy Affected Outcomes in 10,342 Cases With Hematochezia: CODE BLUE-J Study.
10/2007	[Histamine-2 receptor antagonist].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Noriaki Manabe Research Topics

Disease

17	Hemorrhage 02/2024 - 11/2010
17	Gastroesophageal Reflux (GERD) 01/2023 - 01/2010
9	Dyspepsia (Indigestion) 01/2023 - 01/2010
8	Constipation 01/2024 - 01/2010
7	Peptic Ulcer (Peptic Ulcers) 02/2024 - 01/2009
7	Gastrointestinal Hemorrhage (Hematochezia) 01/2024 - 10/2007
6	Atrophy 03/2020 - 01/2008
6	Ulcer 04/2012 - 01/2009
5	Non-Erosive Reflux Disease 01/2022 - 01/2010
5	Peptic Esophagitis (Reflux Esophagitis) 01/2022 - 11/2012
5	Gastritis 01/2022 - 01/2015
5	Infections 03/2020 - 10/2007
4	Neoplasms (Cancer) 01/2023 - 01/2008
4	Atrophic Gastritis 01/2022 - 01/2010
4	Pathologic Constriction (Stenosis) 11/2021 - 12/2014
3	Diarrhea 01/2024 - 10/2010
3	Diverticular Diseases 12/2023 - 01/2019
3	Disease Progression 05/2023 - 12/2017
3	Inflammation (Inflammations) 01/2021 - 01/2010
3	Heartburn (Pyrosis) 01/2021 - 05/2012
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 08/2013 - 06/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2012 - 01/2009
3	Duodenogastric Reflux 12/2010 - 01/2008
3	Hypersensitivity (Allergy) 05/2010 - 07/2008
2	Abdominal Pain (Pain, Abdominal) 01/2024 - 03/2023
2	Adenoma (Adenomas) 09/2022 - 12/2004
2	Adenocarcinoma 01/2022 - 01/2016
2	Deglutition Disorders (Dysphagia) 01/2020 - 01/2017
2	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2019 - 07/2006
2	Globus Sensation 01/2014 - 09/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2012 - 11/2010
2	Stomach Ulcer (Gastric Ulcer) 07/2009 - 10/2007
1	Esophageal Neoplasms (Esophageal Cancer) 02/2024
1	Nausea 01/2024
1	Shock 12/2023
1	Esophageal Achalasia (Megaesophagus) 07/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Colitis 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Thromboembolism 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Ganglion Cysts (Ganglion) 01/2023
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Pain (Aches) 12/2022
1	Hematoma 12/2022
1	Melanosis (Freckles) 09/2022

Drug/Important Bio-Agent (IBA)

22	Proton Pump InhibitorsIBA 01/2023 - 10/2007
11	AcidsIBA 01/2022 - 07/2008
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2012 - 01/2009
5	Indicators and Reagents (Reagents)IBA 02/2024 - 12/2014
5	AntralIBA 03/2020 - 01/2008
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2012 - 10/2007
4	Therapeutic UsesIBA 01/2023 - 12/2004
3	elobixibatIBA 01/2024 - 12/2018
3	PotassiumIBA 01/2022 - 06/2010
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 07/2006
3	liu-jun-zi-tangIBA 08/2016 - 01/2010
3	Type 1 Angiotensin ReceptorIBA 04/2012 - 11/2010
3	prucaloprideIBA 10/2010 - 01/2010
2	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 02/2024 - 01/2022
2	Lansoprazole (Prevacid)FDA LinkGeneric 02/2024 - 06/2016
2	thienopyridineIBA 12/2023 - 11/2010
2	AnticoagulantsIBA 01/2023 - 01/2009
2	Rabeprazole (Aciphex)FDA Link 01/2021 - 11/2012
2	Capsaicin (Zostrix)FDA Link 01/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2016
2	GastrinsIBA 10/2019 - 01/2018
2	Hemostatics (Antihemorrhagics)IBA 12/2017 - 07/2009
2	SonazoidIBA 04/2016 - 12/2010
2	Capsules (Microcapsules)IBA 10/2015 - 12/2014
2	Warfarin (Coumadin)FDA LinkGeneric 01/2015 - 01/2009
2	Serotonin (5 Hydroxytryptamine)IBA 08/2013 - 01/2010
2	AngiotensinogenIBA 04/2012 - 11/2010
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2012 - 03/2012
1	TrimebutineIBA 02/2024
1	linaclotideIBA 01/2024
1	Lubiprostone FDA Link 01/2024
1	Aligeron (AS 2)IBA 11/2023
1	Z 338IBA 07/2023
1	AlbuminsIBA 05/2023
1	Cholinergic Agents (Cholinergics)IBA 03/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Sunitinib (Sutent)FDA Link 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	CytokinesIBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2022
1	AnthraquinonesIBA 09/2022

Therapy/Procedure

19	Therapeutics 01/2023 - 01/2010
7	Cardiopulmonary Resuscitation (CPR) 01/2024 - 11/2021
7	Blood Transfusion (Blood Transfusions) 12/2023 - 12/2017
5	Length of Stay 11/2023 - 01/2023
3	Endoscopic Hemostasis 12/2023 - 01/2021
2	Aftercare (After-Treatment) 02/2024 - 01/2021
2	Ligation 01/2023 - 01/2019
2	Kampo Medicine (Kampo) 06/2010 - 01/2010
1	Chemoradiotherapy 02/2024
1	Neoadjuvant Therapy 02/2024
1	Esophagectomy 02/2024
1	Conservative Treatment 12/2022